Compare XP & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XP | ALGN |
|---|---|---|
| Founded | 2001 | 1997 |
| Country | Cayman Islands | United States |
| Employees | 8069 | N/A |
| Industry | Investment Bankers/Brokers/Service | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 11.3B |
| IPO Year | 2019 | 2000 |
| Metric | XP | ALGN |
|---|---|---|
| Price | $20.78 | $146.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $23.17 | ★ $199.82 |
| AVG Volume (30 Days) | ★ 6.6M | 730.1K |
| Earning Date | 05-19-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | N/A | ★ 3.09 |
| Revenue | N/A | ★ $387,126,000.00 |
| Revenue This Year | $19.00 | $5.78 |
| Revenue Next Year | $13.64 | $4.62 |
| P/E Ratio | ★ $11.42 | $47.78 |
| Revenue Growth | N/A | ★ 23.95 |
| 52 Week Low | $14.80 | $122.00 |
| 52 Week High | $23.13 | $200.44 |
| Indicator | XP | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 70.01 | 35.99 |
| Support Level | $18.57 | N/A |
| Resistance Level | $21.79 | $164.97 |
| Average True Range (ATR) | 0.75 | 4.28 |
| MACD | 0.05 | -0.18 |
| Stochastic Oscillator | 98.69 | 15.66 |
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission. Geographically, the company derives maximum revenue from Brazil and also has its presence in other countries.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.